{
    "nctId": "NCT04274504",
    "briefTitle": "Osteopontin in Metastatic Breast Cancer Patients",
    "officialTitle": "Osteopontin Level and Promoter Polymorphism in Egyptian Metastatic Breast Cancer Patients",
    "overallStatus": "COMPLETED",
    "conditions": "Survival, Prosthesis",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 119,
    "primaryOutcomeMeasure": "Both pretreatment serum level of oteopontin and gene mutation were correlated with different clinicopathological criteria of the patients, response to the treatment, PFS and OS.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* de novo metastatic breast cancer patients recruited from Oncology center Mansoura University and clinical oncology department, Mansoura University Hospital All included patients were presented with disseminated visceral +/- bone metastasis (visceral crisis)\n\nExclusion Criteria:\n\n* brain metastasis was excluded",
    "sex": "FEMALE",
    "minimumAge": "31 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}